Literature DB >> 4294570

Metabolism of vitamin D3-3H in vitamin D-resistant rickets and familial hypophosphatemia.

L V Avioli, T F Williams, J Lund, H F DeLuca.   

Abstract

The fate of an intravenous dose of tritiated vitamin D(3) was studied in seven normal subjects, four children with vitamin D-resistant rickets, and four adults with a familial history of vitamin D-resistant rickets and persistent hypophosphatemia. An abnormal metabolism of vitamin D in vitamin D-resistant rickets was defined and characterized by a decrease in the plasma fractional turnover rate, a marked increase in plasma water-soluble metabolites, and a relative decrease in the conversion of vitamin D to a polar, biologically active metabolite. Alterations in vitamin D metabolism in the adults with persistent hypophosphatemia were similar but less severe than those of affected children with vitamin D-resistant rickets. It is tentatively concluded that the abnormalities in vitamin D metabolism documented in patients with vitamin D-resistant rickets and familial hypophosphatemia may account for the observed osseous and biochemical changes.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4294570      PMCID: PMC292943          DOI: 10.1172/JCI105680

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  VITAMIN D-RESISTANT RICKETS. ANALYSIS OF TWENTY-FOUR PEDIGREES WITH HEREDITARY AND SPORADIC CASES.

Authors:  C H BURNETT; C E DENT; C HARPER; B J WARLAND
Journal:  Am J Med       Date:  1964-02       Impact factor: 4.965

2.  THE PREPARATION OF H3-VITAMINS D2 AND D3--THEIR LOCALIZATION IN THE RAT.

Authors:  A W NORMAN; H F DELUCA
Journal:  Biochemistry       Date:  1963 Sep-Oct       Impact factor: 3.162

3.  The effect of stilboestrol on urinary phosphate excretion.

Authors:  L MULLIGAN; J R NASSIM; P D SAVILLE
Journal:  Clin Sci       Date:  1956-08       Impact factor: 6.124

4.  The effects of cortisone and desoxycorticosterone on the renal tubular reabsorption of phosphate and the excretion of titratable acid and potassium in dogs.

Authors:  K E ROBERTS; R F PITTS
Journal:  Endocrinology       Date:  1953-03       Impact factor: 4.736

5.  The rickets-producing and anti-calcifying action of phytate.

Authors:  E MELLANBY
Journal:  J Physiol       Date:  1949-09       Impact factor: 5.182

6.  Metabolism of tritiated vitamin D.

Authors:  R K Callow; E Kodicek; G A Thompson
Journal:  Proc R Soc Lond B Biol Sci       Date:  1966-02-15

7.  Metabolism of tritiated vitamin D3 in familial vitamin D-resistant rickets with hypophosphatemia.

Authors:  H F DeLuca; J Lund; A Rosenbloom; C C Lobeck
Journal:  J Pediatr       Date:  1967-05       Impact factor: 4.406

8.  Biologically active metabolite of vitamin D3 from bone, liver, and blood serum.

Authors:  J Lund; H F DeLuca
Journal:  J Lipid Res       Date:  1966-11       Impact factor: 5.922

9.  Familial hypophosphatemia. Studies on its pathogenesis in an affected mother and son.

Authors:  G J Magid; J R Maloney; J H Sirota; E A Schwab
Journal:  Ann Intern Med       Date:  1966-05       Impact factor: 25.391

10.  Effect of vitamin D on in vitro bone calcium metabolism.

Authors:  W Y Au; F C Bartter
Journal:  Endocrinology       Date:  1966-06       Impact factor: 4.736

View more
  10 in total

1.  25-hydroxycholecalciferol: effects in idiopathic vitamin D-resistant rickets.

Authors:  S Balsan
Journal:  Calcif Tissue Res       Date:  1970

2.  The role of the liver in the metabolism of vitamin D.

Authors:  G Ponchon; H F DeLuca
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

Review 3.  Recent progress in calcium metabolism: clinical application.

Authors:  G S Gordan
Journal:  Calif Med       Date:  1971-05

Review 4.  Recent advances in the unerstanding and management of metabolic bone disease.

Authors:  R Smith
Journal:  Proc R Soc Med       Date:  1970-09

Review 5.  Metabolic bone disease secondary to renal and intestinal disorders.

Authors:  F P Muldowney
Journal:  Calif Med       Date:  1969-05

6.  The metabolic fate of vitamin D3-3H in chronic renal failure.

Authors:  L V Avioli; S Birge; S W Lee; E Slatopolsky
Journal:  J Clin Invest       Date:  1968-10       Impact factor: 14.808

7.  Metabolites of vitamin D in normal and X-linked hypophosphatemic mice.

Authors:  R A Meyer; M H Meyer; R W Gray
Journal:  Calcif Tissue Int       Date:  1984-12       Impact factor: 4.333

Review 8.  Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis.

Authors:  J W Coburn; D L Hartenbower; A W Norman
Journal:  West J Med       Date:  1974-07

9.  The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma.

Authors:  J E Smith; D S Goodman
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

10.  25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.

Authors:  S Balsan; M Garabedian
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.